Organometallics
Article
7.05 (d, 1H, H5′), 7.19 (m, 1H, H4′), 7.22−7.26 (m, 8H, Hmeta),
7.29−7.40 (m, 9H, Hortho and H3′), 7.73−7.76 (m, 4H, Hpara), 8.02 (s,
Cp*), 2.11−2.21 (m, 2H, PCH2CH2P), 2.61−2.69 (m, 2H,
PCH2CH2P), 7.06 (dd, 1H, H3′), 7.15 (ddd, 1H, H5′), 7.18 (d, 1H,
H4), 7.22−7.41 (m, 12H, Hortho and Hpara), 7.41−7.46 (m, 4H, Hmeta),
7.67−7.73 (m, 4H, Hmeta), 7.89−7.94 (m, 2H, H4′ and H3), 8.18 (s,
1H H6), 8.88 (dd, 1H, H6′). 13C{1H} NMR (CD2Cl2, 151 MHz): δ
10.0 (s, Me5Cp), 29.7 (m, PCH2CH2P), 93.9 (s, Me5Cp), 110.2 (s,
Cβ), 122.1 (s, C3), 122.7 (s, C3), 125.2 (s, C5′), 128.1 (m, Cortho),
129.7 (m, Cpara), 131.4 (s, C5), 133.5 (s, Cmeta), 136.3 (m, Cipso), 138.5
(s, C4′), 139.0 (s, C4), 147.0 (s, C2), 152.9 (s, C6′), 154.3 (s, C2′),
156.9 (s, C2′), 160.0 (m, Cα), 190.7 (s, CO), 198.4 (s, CO). 31P{1H}
3
3
1H, H6), 8.08 (d, 1H, H4, JHH = 8 Hz), 8.25 (d, 1H, H3, JHH = 8
Hz), 8.61 (dd, 1H, H6′). 13C{1H} NMR (CDCl3, 100 MHz): 10.0 (s,
Me5Cp), 29.4 (m, PCH2CH2P), 92.8 (s, Me5Cp), 107.7 (s, Cβ),
120.1(s, C3), 120.6 (s, C3′), 122.5 (s, C5′), 127.4 (t, Phmeta), 127.6 (t,
Phmeta), 129.2 (s, Phpara), 133.3 (t, Phortho), 136.4 (s, C5), 136.8 (s,
1
4
C4′) 137.4 (s, C4), 138.7 (dd, Cipso, JCP = 39.7 Hz, JCP = 6.4 Hz),
2
141.0 (t, Cα, JCP = 24.4 Hz), 149.0 (s, C2), 149.1 (s, C6′), 151.0 (s,
C6), 157.0 (s, C2′). 31P{1H} NMR (CDCl3, 162 MHz): 79.72 ppm
(s). IR (CH2Cl2 solution): νCC 2067 cm−1 (2044 cm−1 shoulder).
MS (MALDI): m/z 814 ([M]+, 100%), 663 ([Ru(CO)(dppe)Cp*]+,
90%), 635 ([Ru(dppe)Cp*]+, 30%). UV−vis (CH2Cl2) λ (nm) [ε ×
104 M−1 cm−1]: 399 [2.37].
3
3
NMR (CD2Cl2, 243 MHz): 80.86 (d, JPP = 16 Hz), 80.62 (d, JPP
=
16 Hz). IR (CH2Cl2 solution): νCC 2038 cm−1, νCO 2018 cm−1,
νCO 1915 cm−1, and νCO 1893 cm−1. MS (MALDI): m/z 663
([Ru(CO)(dppe)Cp*]+, 100%), 635 ([Ru(dppe)Cp*]+, 70%), 1120
([M]+, 5%). UV−vis (CH2Cl2) λ (nm) [ε × 104 M−1 cm−1]: 387
[1.21], 506 [1.72].
[Ru(CCbpy)(PPh3)2Cp] (2). [RuCl(PPh3)2Cp] (400 mg, 0.551
mmol), HCCbpy (150 mg, 0.826 mmol), and NH4PF6 (200 mg,
1.23 mmol) were refluxed in MeOH for 2 h, during which the yellow
suspension became a deep red solution. The solution was cooled to
room temperature before the addition of DBU (0.5 mL), followed by
30 min of stirring, resulting in the formation of a yellow precipitate.
The mixture was cooled to 0 °C, and the reaction product was
collected on a glass frit and washed with MeOH (2 × 5 mL) to give
the product as a yellow powder (348 mg, 73%). Crystals suitable for X-
ray analysis were obtained through the slow diffusion of hexane into a
CDCl3 solution of the complex. This complex matches the
spectroscopic data presented previously,31 with the following revised
13C{1H} assignments; 13C{1H} (CDCl3, 151 MHz): δ 85.5 (s, Cp),
112.2 (s, Cβ), 120.3 (s, C3), 120.8 (s, C3′), 122.7 (s, C5′), 127.2 (s,
[Ru(CCbpy-κ2-N′N-RuClCp)(PPh3)2Cp] (6). [Ru(CCbpy)-
(PPh3)2Cp] (2) (100 mg, 0.115 mmol) and [RuCl(COD)Cp] (38
mg, 0.123 mmol) were dissolved in acetone (30 mL), and the solution
was stirred at room temperature overnight. The solvent volume was
reduced to ca. 10 mL in vacuo, followed by the addition of diethyl
ether (30 mL) and cooling to −15 °C. The precipitate that formed was
collected and washed with diethyl ether (2 × 5 mL) to give the
product as purple crystals (92 mg, 75%). Crystals suitable for X-ray
analysis were obtained through layer diffusion of hexane into a CH2Cl2
solution of the complex. Anal. Calcd for C58H47ClN2P2Ru2: C, 65.01;
H, 4.42; N, 2.61. Found: C, 64.89; H, 4.51; N, 2.53. 1H NMR
(CD2Cl2, 500 MHz): δ 4.18 (s, 5H, Cpbpy), 4.42 (s, 5H, CpPP), 7.13−
7.21 (m, 13H, Hmeta and H5′), 7.26−7.30 (m, 7H, Hpara and H3′),
7.43−7.52 (m, 12H, Hortho), 7.68 (dd, (1H, H4′), 7.75 (d, 1H, H3),
7.84, (d, 1H, H4), 9.29, (d, 1H, H6), 9.55 (d, 1H, H6′). 13C{1H}
NMR (CD2Cl2, 126 MHz): δ 69.3 (s, Cpbpy), 86.1 (s, CpPP), 112.6 (s,
Cβ), 121.0 (s, C3), 121.3 (s, C3′), 123.6 (s, C5′), 127.8 (m, Cmeta),
128.5 (s, C5), 129.2 (s, Cpara), 134.6 (m, Cortho and C4′), 135.7 (s, C4),
137.0 (t, Cα, 2JCP = 24.3 Hz), 138.9 (m, Cipso), 149.3 (s, C2), 155.2 (s,
C6′), 156.7 (m, C6 and C2′). 31P{1H} NMR (CDCl3, 162 MHz): δ
49.29 (s), 49.26 (s). IR (CH2Cl2 solution): νCC 2045 cm−1. MS
(MALDI): m/z 719 ([Ru(CO)(PPh3)2Cp]+, 100%), 1036 ([M −
Cl]+, 15%), 774 ([M − PPh3 − Cl]+, 12%), 1072 ([M + H]+, 5%).
UV−vis (CH2Cl2) λ (nm) [ε × 104 M−1 cm−1]: 295 [2.43], 374
[1.31], 434 [2.36].
2
2
C5), 127.3 (t, JCP = 4.4 Hz, Cortho), 128.4 (t, JCP = 25.7 Hz, Cα),
128.7 (s, Cpara), 133.9 (t, 3JCP = 4.8 Hz, Cmeta), 136.8 (s, C4′), 138.0 (s,
1
C4), 138.8 (t, JCP = 21.0 Hz, Cipso), 149.2 (s, C6′), 149.7 (s, C2),
151.2 (s, C6), 156.9 (s, C2′).
[Ru(CCbpy-κ2-N′N-RuClCp)(dppe)Cp*] (4). [Ru(CCbpy)-
(dppe)Cp*](1) (50 mg, 0.061 mmol) and [RuCl(COD)Cp] (20
mg, 0.065 mmol) were dissolved in acetone (30 mL) and stirred at
room temperature overnight. The solvent volume was reduced to ca.
10 mL in vacuo, followed by the addition of diethyl ether (30 mL) and
cooling to −15 °C. The precipitate that formed was collected and
washed with diethyl ether (2 × 5 mL) to give the product as purple
crystals (43 mg, 69%). Anal. Calcd for C53H51ClN2P2Ru2: C, 62.68; H,
1
5.06; N, 2.76. Found: C, 62.55; H, 4.95; N, 2.86. H NMR (CD2Cl2,
[Ru(CCbpy-κ2-N′N-ReCl(CO)3)(PPh3)2Cp] (7). [Ru(CCbpy)-
(PPh3)2Cp] (2) (55 mg, 0.063 mmol) and [ReCl(CO)5] (26 mg,
0.072 mmol) were dissolved in toluene (30 mL), and the solution was
refluxed for 2 h, during which a bright yellow solution became deep
red. The solvent volume was reduced to ca. 5 mL in vacuo, followed by
the addition of hexane (20 mL) and cooling to −15 °C overnight. The
precipitate that formed was collected and washed with hexane (3 × 5
mL) to give the product as a red powder (38 mg, 51%). Crystals
suitable for X-ray crystallography were grown through vapor diffusion
of n-pentane into a CD2Cl2 solution of the compound. Anal. Calcd for
C56H42ClN2O3P2ReRu·1.5CH2Cl2: C, 53.00; H, 3.48; N, 2.15. Found:
600 MHz): 1.59 (s, 15H, Cp*), 2.16 (m, 2H, PCH2CH2P), 2.68 (m,
2H, PCH2CH2P), 4.11 (s, 5H, Cp), 6.92 (d, 1H, H3′), 7.18 (ddd, 1H,
H5′), 7.21−7.29 (m, 4H, Hmeta), 7.33−7.43 (m, 8H, Hortho and Hmeta),
7.44−7.48 (m, 4H, Hpara), 7.60 (d, 1H, H4, 3JHH = 8.4 Hz), 7.65 (ddd,
1H, H4′), 7.72−7.80 (m, 5H, Hortho and H3), 8.79 (s, 1H, H6), 9.50
(d, 1H, H6′). 13C{1H} NMR (CD2Cl2, 151 MHz): δ 10.2 (s, Me5Cp),
29.8 (m, PCH2CH2P), 69.2 (s, Cp), 93.5 (s, Me5Cp), 108.6 (s, Cβ),
120.8 (s, C3), 121.1 (s, C3′), 123.4 (s, C5′), 127.9 (m, Cmeta), 129.1
(s, C5), 129.6 (m, Cpa1ra), 133.7 (m, Cortho), 134.6 (s, C4′), 135.8 (s,
4
C4), 138.8 (dd, Cipso, JCP = 72.9 Hz, JCP = 34.0 Hz), 148.7 (s, C2),
2
150.1 (t, Cα, JCP = 24.0 Hz), 155.1 (s, C6′), 156.0 (s, C6), 156.8 (s,
1
3
C2′). 31P{1H} NMR (CD2Cl2, 243 MHz): 81.17 (d, JPP = 16 Hz),
C, 53.40; H, 3.25; N, 2.14. H NMR: δ 4.43 (s, 5H, Cp), 7.10 (ddd,
3
80.90 (d, JPP = 16 Hz). IR (CH2Cl2 solution): νCC 2042 cm−1. MS
1H, H5′), 7.15−7.18 (m, 12H, Hortho), 7.26−7.29 (m, 6H, Hpara),
7.38−7.45 (m, 13H, Hmeta and H3′), 7.89 (d, 1H, H4), 8.00 (m, 2H,
H3 and H4′), 8.63 (d, 1H, H6), 8.94 (d, 1H, H6′). 13C{1H} NMR
(CD2Cl2, 151 MHz): δ 86.4 (s, Cp), 113.7 (s, Cβ), 122.3 and 122.9 (s,
C3 and C3′), 125.5 (s, C5′), 127.9 (s, Cortho), 129.3 (s, Cpara), 130.8 (s,
C4′), 131.6 (s, C4), 132.3 (s, C5), 134.0 (m, Cmeta), 138.8 (m, Cipso),
146.6 (m, Cα), 147.8 (s, C2), 153.0 (s, C6′), 154.6 (s, C6), 156.8 (s,
C2′), 190.6 (s, CO), 198.4 (s, CO). 31P{1H} NMR (CDCl3, 162
MHz): δ 49.1 (s). IR (CH2Cl2 solution): νCC 2043 cm−1, νCO 2019
cm−1, νCO 1916 cm−1 and νCO 1894 cm−1. MS (MALDI): m/z 719
([Ru(CO)(PPh3)2Cp]+, 100%), 691 ([Ru(PPh3)2Cp]+, 20%), 1140
([M − Cl]+, 5%). UV−vis (CH2Cl2) λ (nm) [ε × 104 M−1 cm−1]: 302
[1.98], 481 [1.79].
(MALDI): m/z 981 ([M − Cl]+, 100%), 663 ([Ru(CO)(dppe)Cp*]+,
50%), 635 ([Ru(dppe)Cp*]+, 30%), 1015 ([M]+, 10%), 814 ([M −
RuClCp]+, 10%). UV−vis (CH2Cl2) λ (nm) [ε × 104 M−1 cm−1]: 299
[1.75], 367 [1.42], 450 [1.84].
[Ru(CCbpy-κ2-N′N-ReCl(CO)3)(dppe)Cp*] (5). [Ru(CCbpy)-
(dppe)Cp*](1) (70 mg, 0.086 mmol) and [ReCl(CO)5] (33 mg,
0.091 mmol) were dissolved in toluene (40 mL), and the solution was
refluxed for 2 h, during which a bright yellow solution became deep
purple. The solvent volume was reduced to ca. 10 mL in vacuo,
followed by the addition of hexane (20 mL) and cooling to 0 °C. The
precipitate was collected and washed with hexane (3 × 3 mL) to give
the product as purple crystals (77 mg, 80%). Crystals suitable for X-ray
analysis were obtained through the slow diffusion of hexane into a
CDCl3 solution of the complex. Anal. Calcd for
C51H46ClN2O3P2Re1Ru1: C, 54.71; H, 4.14; N, 2.50. Found: C,
54.78; H, 4.12; N, 2.60. 1H NMR (CD2Cl2, 600 MHz): δ 1.60 (s, 15H
[Ru(CCbpy-κ2-N′N-RuClCp)Cl(dppm)2](8). [Ru(CCbpy)Cl-
(dppm)2] (85 mg, 0.078 mmol) and [RuCl(COD)Cp] (30 mg,
0.097 mmol) were dissolved in acetone (15 mL), and the solution was
stirred at room temperature overnight. The solvent volume was
4913
dx.doi.org/10.1021/om500172r | Organometallics 2014, 33, 4911−4922